The Sensex closed 931 points, or 1.22 per cent, down at 75,364.69, while the Nifty 50 ended with a loss of 346 points, or ...

Mumbai: Benchmark indices Sensex and Nifty closed down on Thursday due to selling in IT shares amid a global sell-off as US ...

All the other sectoral indices on the NSE were traded in red while metal, pharma and realty shares declining the most.

Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, after U.S. President Donald ...

As per Geojit Investments report, Zydus Lifesciences' 47 percentage of revenue comes from the US. Similarly, Aurobindo Pharma ...

Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...

IT shares were the top Sensex and sectoral losers over fears of recession as experts see additional tariffs detrimental to ...

Donald Trump's reciprocal tariff announcement to mark ‘liberation day’ for the US increased fears of a global recession due ...

President Trump spares tariffs on pharmaceuticals, but says that he is worried about supply issues given most drugs in the ...

The program saw success in select areas like mobile phone and pharmaceutical manufacturing. India produced $49 billion worth of mobile phones in 2023-24, with major players like Apple shifting ...

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

India’s specialty chemicals sector is showing early signs of recovery in Q4 FY25, while pharmaceutical exports continue to grow at 8-9%, driven by strong demand for drugs like gRevlimid (blood ...